Clinicopathological Characteristics and Lymph Node Metastasis Rates in Early Gastric Lymphoepithelioma-Like Carcinoma: Implications for Endoscopic Resection
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: Lymphoepithelioma-like carcinoma (LELC) is a rare subtype of gastric cancer. We aimed to identify the clinicopathological features and rate of lymph node metastasis (LNM) to investigate the feasibility of endoscopic submucosal dissection for early gastric LELC confined to the mucosa or submucosa. Methods: We compared the clinicopathological characteristics of 116 early gastric LELC patients and 5,753 early gastric well- or moderately differentiated (WD or MD) tubular adenocarcinoma patients treated by gastrectomy. Results: Compared to WD or MD early gastric cancer (EGC) patients, early LELC patients were younger and had a higher prevalence of proximally located tumors. Despite more frequent deep submucosal invasion (86.2% vs 29.8%), lymphatic invasion was less frequent (6.0% vs 16.2%) in early LELC patients than in WD or MD EGC patients. Among tumors with deep submucosal invasion, the tumor size was smaller, lymphatic invasion was less frequent (6.0% vs 40.2%) and the rate of LNM was lower (10.0% vs 19.4%) in patients with LELC than in those with WD or MD EGC. The overall rate of LNM in early LELC patients was 8.6% (10/116). The risk of LNM in patients with mucosal, shallow submucosal invasive, or deep submucosal invasive LELC was 0% (0/6), 0% (0/10), and 10% (10/100), respectively. Conclusions: Early LELC is a distinct subtype of EGC with more frequent deep submucosal invasion but less lymphatic invasion and LNM than WD or MD EGCs. Endoscopic submucosal dissection may be considered curative for patients with early LELC confined to the mucosa or shallow submucosa, given its negligible rate of LNM.
Abstract
Background/Aims: Lymphoepithelioma-like carcinoma (LELC) is a rare subtype of gastric cancer. We aimed to identify the clinicopathological features and rate of lymph node metastasis (LNM) to investigate the feasibility of endoscopic submucosal dissection for early gastric LELC confined to the mucosa or submucosa. Methods: We compared the clinicopathological characteristics of 116 early gastric LELC patients and 5,753 early gastric well- or moderately differentiated (WD or MD) tubular adenocarcinoma patients treated by gastrectomy. Results: Compared to WD or MD early gastric cancer (EGC) patients, early LELC patients were younger and had a higher prevalence of proximally located tumors. Despite more frequent deep submucosal invasion (86.2% vs 29.8%), lymphatic invasion was less frequent (6.0% vs 16.2%) in early LELC patients than in WD or MD EGC patients. Among tumors with deep submucosal invasion, the tumor size was smaller, lymphatic invasion was less frequent (6.0% vs 40.2%) and the rate of LNM was lower (10.0% vs 19.4%) in patients with LELC than in those with WD or MD EGC. The overall rate of LNM in early LELC patients was 8.6% (10/116). The risk of LNM in patients with mucosal, shallow submucosal invasive, or deep submucosal invasive LELC was 0% (0/6), 0% (0/10), and 10% (10/100), respectively. Conclusions: Early LELC is a distinct subtype of EGC with more frequent deep submucosal invasion but less lymphatic invasion and LNM than WD or MD EGCs. Endoscopic submucosal dissection may be considered curative for patients with early LELC confined to the mucosa or shallow submucosa, given its negligible rate of LNM.
참고문헌 (21)
- Lauwers GY, "WHO Classification of Tumours of the Digestive System", pp.48~58 (2010), IARC Press
- Lim H, "Features of gastric carcinoma with lymphoid stroma associated with Epstein-Barr virus", Clin Gastroenterol Hepatol, 13, pp.1738~1744 (2015)
- Nakamura S, "Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis", Cancer, 73, pp.2239~2249 (1994)
- Huang KH, "Advanced gastric cancer patients with lymphoid stroma have better survival than those without", J Surg Oncol, 107, pp.523~528 (2013)
- Song HJ, "Host inflammatory response predicts survival of patients with Epstein-Barr virus-associated gastric carcinoma", Gastroenterology, 139, pp.84~92 (2010)
- Lim H, "Clinical application of early gastric carcinoma with lymphoid stroma based on lymph node metastasis status", Gastric Cancer, 20, pp.793~801 (2017)
- Shin DH, "Clinicopathologic features of early gastric carcinoma with lymphoid stroma and feasibility of endoscopic submucosal dissection", Surg Endosc, 31, pp.4156~4164 (2017)
- Huh CW, "Clinicopathologic features of gastric carcinoma with lymphoid stroma in early gastric cancer", J Surg Oncol, 114, pp.769~772 (2016)
- Japanese Gastric Cancer Association, "Japanese gastric cancer treatment guidelines 2014(ver. 4)", Gastric Cancer, 20, pp.1~19 (2017)
- Lee JH, "Clinical practice guidelines for gastric cancer in Korea : an evidence-based approach", J Gastric Cancer, 14, pp.87~104 (2014)
- Kim WH, "A standardized pathology report for gastric cancer", Korean J Pathol, 39, pp.106~113 (2005)
- Amin MB, "AJCC Cancer Staging Manual" (2018), Springer International Publishing
- Min BH, "Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma", Gastric Cancer, 19, pp.852~859 (2016)
- "The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002", Gastrointest Endosc, 58(6 Suppl), pp.S3~S43 (2003)
- Watanabe H, "Gastric carcinoma with lymphoid stroma : its morphologic characteristics and prognostic correlations", Cancer, 38, pp.232~243 (1976)
- Kurihara N, "Lymph node metastasis of early gastric cancer with submucosal invasion", Br J Surg, 85, pp.835~839 (1998)
- Cheng Y, "Very low risk of lymph node metastasis in Epstein-Barr virus-associated early gastric carcinoma with lymphoid stroma", BMC Gastroenterol, 20, pp.273~ (2020)
- Iwasaki K, "Postoperative outcomes of gastric carcinoma with lymphoid stroma", World J Surg Oncol, 18, pp.102~ (2020)
- Gullo I, "New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma : from morphology and digital analysis to gene expression", Gastric Cancer, 22, pp.77~90 (2019)
- Japanese Gastric Cancer Association, "Japanese gastric cancer treatment guidelines 2021(6th edition)", Gastric Cancer, 26, pp.1~25 (2023)
- Lim H, "A single-center experience of endoscopic resection for early gastric cancer with lymphoid stroma", J Gastric Cancer, 18, pp.400~408 (2018)